XML 82 R26.htm IDEA: XBRL DOCUMENT v3.20.1
Guarantor and Non-Guarantor Financial Information
3 Months Ended
Mar. 28, 2020
Guarantor and Non-Guarantor Financial Information  
Guarantor and Non-Guarantor Financial Information

(18)

Guarantor and Non-Guarantor Financial Information

As further discussed in Note 6, “Long-Term Debt,” our obligations under the 4.625% senior notes due 2021 were, and our obligations under the 5.25% senior notes due 2025 and the 5.25% senior notes due 2027 are, jointly and severally and fully and unconditionally guaranteed on a senior basis by all of our existing and certain future domestic subsidiaries, which we refer to in this note as the guarantor subsidiaries. Our foreign subsidiaries, which we refer to in this note as the non-guarantor subsidiaries, do not guarantee the 5.25% senior notes due 2025 or the 5.25% senior notes due 2027. We redeemed all of our 4.625% senior notes due 2021 on October 10, 2019. See Note 6, “Long-Term Debt.”

The following unaudited condensed consolidating financial information presents the condensed consolidating balance sheet as of March 28, 2020 and December 28, 2019, the related condensed consolidating statement of operations for the thirteen weeks ended March 28, 2020 and March 30, 2019 and the related condensed consolidating statement of cash flows for the thirteen weeks ended March 28, 2020 and March 30, 2019 for:

1.B&G Foods, Inc. (the Parent),

2.the guarantor subsidiaries,

3.the non-guarantor subsidiaries, and

4.the Parent and all of its subsidiaries on a consolidated basis.

The information includes elimination entries necessary to consolidate the Parent with the guarantor subsidiaries and non-guarantor subsidiaries. The guarantor subsidiaries and non-guarantor subsidiaries are presented on a combined basis. The principal elimination entries eliminate investments in subsidiaries and intercompany balances and

transactions. Separate financial information for each of the guarantor subsidiaries and non-guarantor subsidiaries are not presented because management believes such financial statements would not be meaningful to investors.

Condensed Consolidating Balance Sheet

As of March 28, 2020

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Assets

Current assets:

Cash and cash equivalents

$

$

117,171

$

9,897

$

$

127,068

Trade accounts receivable, net

 

 

179,540

21,023

 

200,563

Inventories, net

 

 

344,207

54,982

 

399,189

Prepaid expenses and other current assets

 

 

19,815

6,000

 

25,815

Income tax receivable

 

 

18,470

617

 

19,087

Intercompany receivables

 

 

26,209

 

 

(26,209)

 

Total current assets

 

 

705,412

 

92,519

 

(26,209)

 

771,722

Property, plant and equipment, net

 

 

253,910

35,730

 

289,640

Operating lease right-of-use assets, net

38,260

53

38,313

Goodwill

 

 

599,557

 

599,557

Other intangible assets, net

 

 

1,610,404

 

1,610,404

Other assets

 

 

3,090

101

 

3,191

Deferred income taxes

 

 

5,957

 

5,957

Investments in subsidiaries

 

2,826,207

 

91,550

(2,917,757)

 

Total assets

$

2,826,207

$

3,302,183

$

134,360

$

(2,943,966)

$

3,318,784

Liabilities and Stockholders' Equity

Current liabilities:

Trade accounts payable

$

$

91,778

$

10,851

$

$

102,629

Accrued expenses

 

55,218

3,961

 

59,179

Current portion of operating lease liabilities

10,763

43

10,806

Current portion of long-term debt

 

4,500

 

4,500

Income tax payable

1,728

1,728

Dividends payable

 

30,457

 

30,457

Intercompany payables

 

26,209

(26,209)

 

Total current liabilities

 

34,957

 

157,759

 

42,792

 

(26,209)

 

209,299

Long-term debt

 

1,994,963

(20,102)

 

1,974,861

Deferred income taxes

 

268,854

 

268,854

Long-term operating lease liabilities, net of current portion

30,495

18

30,513

Other liabilities

 

38,970

 

38,970

Total liabilities

 

2,029,920

 

475,976

 

42,810

 

(26,209)

 

2,522,497

Stockholders' equity:

Preferred stock

Common stock

 

641

 

641

Additional paid-in capital

 

1,963,342

68,253

(2,031,595)

 

Accumulated other comprehensive loss

 

(45,947)

(45,948)

(21,484)

67,432

 

(45,947)

Retained earnings

 

841,593

908,813

44,781

(953,594)

 

841,593

Total stockholders’ equity

 

796,287

 

2,826,207

 

91,550

 

(2,917,757)

 

796,287

Total liabilities and stockholders’ equity

$

2,826,207

$

3,302,183

$

134,360

$

(2,943,966)

$

3,318,784

Condensed Consolidating Balance Sheet

As of December 28, 2019

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Assets

Current assets:

Cash and cash equivalents

$

$

6,955

$

4,360

$

$

11,315

Trade accounts receivable, net

 

 

130,289

13,619

 

 

143,908

Inventories, net

 

 

399,935

72,252

 

 

472,187

Prepaid expenses and other current assets

 

 

18,393

7,056

 

 

25,449

Income tax receivable

 

 

8,311

623

 

 

8,934

Intercompany receivables

 

 

 

(12,609)

 

12,609

 

Total current assets

 

 

563,883

 

85,301

 

12,609

 

661,793

Property, plant and equipment, net

 

 

260,256

44,678

 

304,934

Operating lease right-of-use assets, net

 

38,632

66

 

38,698

Goodwill

 

 

596,391

 

596,391

Other intangible assets, net

 

 

1,615,126

 

1,615,126

Other assets

 

 

3,263

14

 

3,277

Deferred income taxes

 

 

7,371

 

7,371

Investments in subsidiaries

 

2,743,615

 

100,561

(2,844,176)

 

Total assets

$

2,743,615

$

3,178,112

$

137,430

$

(2,831,567)

$

3,227,590

Liabilities and Stockholders' Equity

Current liabilities:

Trade accounts payable

$

$

100,488

$

14,448

$

$

114,936

Accrued expenses

 

 

51,951

3,708

 

 

55,659

Current portion of operating lease liabilities

9,768

45

9,813

Current portion of long-term debt

 

5,625

 

 

 

5,625

Income tax payable

125

329

454

Dividends payable

 

30,421

 

 

 

30,421

Intercompany payables

 

 

(30,917)

18,308

 

12,609

 

Total current liabilities

 

36,046

 

131,415

 

36,838

 

12,609

 

216,908

Long-term debt

 

1,895,027

 

(20,869)

 

 

1,874,158

Deferred income taxes

 

 

254,339

 

 

254,339

Long-term operating lease liabilities, net of current portion

31,966

31

31,997

Other liabilities

 

 

37,646

 

 

37,646

Total liabilities

 

1,931,073

 

434,497

 

36,869

 

12,609

 

2,415,048

Stockholders' equity:

Preferred stock

Common stock

 

640

 

 

 

640

Additional paid-in capital

 

 

1,894,788

68,253

 

(1,963,041)

 

Accumulated other comprehensive loss

 

(31,894)

 

(31,894)

(7,133)

 

39,027

 

(31,894)

Retained earnings

 

843,796

 

880,721

39,441

 

(920,162)

 

843,796

Total stockholders’ equity

 

812,542

 

2,743,615

 

100,561

 

(2,844,176)

 

812,542

Total liabilities and stockholders’ equity

$

2,743,615

$

3,178,112

$

137,430

$

(2,831,567)

$

3,227,590

Condensed Consolidating Statement of Operations and Comprehensive Income

Thirteen Weeks Ended March 28, 2020

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Net sales

$

$

495,892

$

59,499

$

(106,021)

$

449,370

Cost of goods sold

 

 

400,732

 

49,743

 

(106,021)

 

344,454

Gross profit

 

 

95,160

 

9,756

 

 

104,916

Operating expenses:

Selling, general and administrative expenses

 

37,940

2,033

 

39,973

Amortization expense

 

4,723

 

4,723

Operating income

 

 

52,497

 

7,723

 

 

60,220

Other income and expenses:

Interest expense, net

 

26,039

 

26,039

Other income

(453)

(453)

Income before income tax expense

 

 

26,911

 

7,723

 

 

34,634

Income tax expense

 

4,159

2,383

 

6,542

Equity in earnings of subsidiaries

28,092

5,340

(33,432)

Net income

$

28,092

$

28,092

$

5,340

$

(33,432)

$

28,092

Comprehensive income (loss)

$

14,039

$

27,796

$

(9,009)

$

(18,787)

$

14,039

Condensed Consolidating Statement of Operations and Comprehensive Income

Thirteen Weeks Ended March 30, 2019

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Net sales

$

$

390,167

$

55,025

$

(32,458)

$

412,734

Cost of goods sold

 

 

306,300

 

50,813

 

(32,458)

 

324,655

Gross profit

 

 

83,867

 

4,212

 

 

88,079

Operating expenses:

Selling, general and administrative expenses

 

40,055

(1,758)

 

38,297

Amortization expense

 

4,491

 

4,491

Operating income

 

 

39,321

 

5,970

 

 

45,291

Other income and expenses:

Interest expense, net

 

23,074

 

23,074

Other income

(258)

(258)

Income before income tax expense

 

 

16,505

 

5,970

 

 

22,475

Income tax expense

 

5,772

(88)

 

5,684

Equity in earnings of subsidiaries

16,791

6,058

(22,849)

Net income

$

16,791

$

16,791

$

6,058

$

(22,849)

$

16,791

Comprehensive income

$

18,411

$

16,629

$

7,516

$

(24,145)

$

18,411

Condensed Consolidating Statement of Cash Flows

Thirteen Weeks Ended March 28, 2020

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Net cash provided by operating activities

$

$

46,296

$

11,282

$

$

57,578

Cash flows from investing activities:

Capital expenditures

 

 

(5,827)

(314)

 

(6,141)

Payments for acquisition of businesses, net of cash acquired

 

 

(3,419)

 

(3,419)

Net cash used in investing activities

 

 

(9,246)

 

(314)

 

 

(9,560)

Cash flows from financing activities:

Repayments of long-term debt

 

(1,125)

 

(1,125)

Repayments of borrowings under revolving credit facility

 

(60,000)

 

(60,000)

Borrowings under revolving credit facility

 

160,000

 

160,000

Dividends paid

 

(30,421)

 

(30,421)

Intercompany transactions

(68,454)

73,166

(4,712)

Net cash provided by (used in) financing activities

 

 

73,166

 

(4,712)

 

68,454

Effect of exchange rate fluctuations on cash and cash equivalents

 

(719)

 

(719)

Net increase in cash and cash equivalents

 

 

110,216

 

5,537

 

 

115,753

Cash and cash equivalents at beginning of period

 

 

6,955

 

4,360

 

 

11,315

Cash and cash equivalents at end of period

$

$

117,171

$

9,897

$

$

127,068

Condensed Consolidating Statement of Cash Flows

Thirteen Weeks Ended March 30, 2019

(In thousands)

    

    

Guarantor

    

Non-Guarantor

    

    

Parent

Subsidiaries

Subsidiaries

Eliminations

Consolidated

Net cash provided by operating activities

$

$

43,330

$

7,014

$

$

50,344

Cash flows from investing activities:

Capital expenditures

 

 

(7,802)

(846)

 

(8,648)

Net cash used in investing activities

 

 

(7,802)

 

(846)

 

 

(8,648)

Cash flows from financing activities:

Repayments of borrowings under revolving credit facility

 

(40,000)

 

(40,000)

Borrowings under revolving credit facility

 

40,000

 

40,000

Dividends paid

 

(31,178)

 

(31,178)

Payments for the repurchase of common stock, net

(10,000)

(10,000)

Payments of tax withholding on behalf of employees for net share settlement of share-based compensation

 

(905)

 

(905)

Intercompany transactions

41,178

(34,389)

(6,789)

Net cash used in financing activities

 

 

(35,294)

 

(6,789)

 

(42,083)

Effect of exchange rate fluctuations on cash and cash equivalents

 

 

 

23

 

 

23

Net increase (decrease) in cash and cash equivalents

 

 

234

 

(598)

 

 

(364)

Cash and cash equivalents at beginning of period

 

 

9,871

 

1,777

 

 

11,648

Cash and cash equivalents at end of period

$

$

10,105

$

1,179

$

$

11,284